Instituto Nacional de Saúde., Centro de Investigação em Saúde da Manhiça (CISM), the global alliance for diagnostics - FIND, Ifakara Health Institute, Mbeya Medical Research Center, the global alliance for diagnostics - FIND, the global alliance for diagnostics - FIND, Biomedical Research & Training Institute - The Health Research Unit Zimbabwe, Barcelona Institute for Global Health (ISGlobal) - Centro de Investigação em Saude de Manhiça (CISM), Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, World Health Organization (WHO) - Global Tuberculosis Programme, Centro de Investigação em Saúde da Manhiça (CISM), Centro de Investigação em Saúde da Manhiça (CISM), Centro de Investigação em Saúde da Manhiça (CISM), National Institute for Medical Research (NIMR), Mbeya Medical Research Center, Mbeya Medical Research Center, Ifakara Health Institute, Ifakara Health Institute, Instituto Nacional de Saúde., Instituto Nacional de Saúde., University of North Carolina (UNC) at Chapel Hill - National Institute of Health, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, the global alliance for diagnostics - FIND, Foundation for Innovative New Diagnostics (FIND), London School of Hygiene & Tropical Medicine - Department of Clinical Research and Independent

Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centro de Investigação em Saúde da Manhiça (CISM), Centro de Investigação em Saúde da Manhiça (CISM), Centro de Investigação em Saúde da Manhiça (CISM), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Universitat de Barcelona, Centro de Investigação em Saúde da Manhiça (CISM), Centro de Investigação em Saúde da Manhiça (CISM), Hospital Distrital da Manhiça, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centro de Investigação em Saúde da Manhiça (CISM), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit and Centro de Investigação em Saúde da Manhiça (CISM)